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Abstract
Background: p68 (Ddx5) and p72 (Ddx17) are highly related members of the DEAD box family
and are established RNA helicases. They have been implicated in growth regulation and have been
shown to be involved in both pre-mRNA and pre-rRNA processing. More recently, however, these
proteins have been reported to act as transcriptional co-activators for estrogen-receptor alpha
(ERα). Furthermore these proteins were shown to interact with co-activators p300/CBP and the
RNA polymerase II holoenzyme. Taken together these reports suggest a role for p68 and p72 in
transcriptional activation.
Results: In this report we show that p68 and p72 can, in some contexts, act as transcriptional
repressors. Targeting of p68 or p72 to constitutive promoters leads to repression of transcription;
this repression is promoter-specific. Moreover both p68 and p72 associate with histone
deacetylase 1 (HDAC1), a well-established transcriptional repression protein.
Conclusions: It is therefore clear that p68 and p72 are important transcriptional regulators,
functioning as co-activators and/or co-repressors depending on the context of the promoter and
the transcriptional complex in which they exist.
Background
The DEAD/H box family of RNA helicases has been dem-
onstrated to be involved in virtually all processes that
require manipulation of RNA including transcription,
pre-mRNA and pre-rRNA processing, RNA export, ribos-
ome assembly and translation [1]. Although, in vitro, sev-
eral members of this family have been shown to unwind
RNA duplexes, relatively few appear to be true processive
helicases and it is clear that, in the cell, many are likely to
be involved in unwinding of short base paired regions of
RNA or in the modulation of RNA-protein interactions.
DNA helicases belong to a superfamily of proteins that is
distantly related to DEAD/H box RNA helicases and
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Xeroderma pigmentosum XPB and XPD proteins [3],
which have well established roles in transcription.
Although the functions of DEAD/H box RNA helicases in
other cellular processes, such as pre-mRNA processing
and translation have been well studied, their role in tran-
scriptional regulation is only now emerging. Examples of
DEAD/H box RNA helicases involved in transcription
include RNA helicase II (RHII/Gu) and RNA helicase A
(RHA/NDHII). RHII/Gu was demonstrated to be a cofac-
tor for c-Jun-activated transcription [4] and was shown to
translocate from the nucleolus to the nucleoplasm after
UV or anisomycin treatment (which activates JNK signal-
ling). Although RHII/Gu was found to associate with
phosphorylated c-Jun in a non-phosphorylated state, this
association was observed to increase after anisomycin
treatment, implying a stronger interaction when c-Jun is
phosphorylated [4]. RHA is a homologue of the Drosophila
maleless (MLE) gene product [5] and is thought to be
important for gene dosage compensation on the X-chro-
mosome [6]. RHA has been shown to be required for com-
plex formation between the transcriptional co-activator,
CREB binding protein (CBP), and RNA polymerase II [7].
Furthermore, different regions of the RNA helicase protein
were found to interact with both CBP and RNA polymer-
ase II. The association of RHA with RNA polymerase II was
further investigated, and narrowed down to a 50 amino
acid stretch, outwith the conserved helicase motifs [7];
this study also showed that RHA could regulate CREB-
dependent transcription either through recruitment of Pol
II or by ATP-dependent mechanisms. A later study
reported that RHA acts as a bridging molecule between the
breast tumour specific transcriptional activator, BRCA1
and the RNA polymerase II holoenzyme complex [8].
These reports thus provide clear evidence of a role for RNA
helicases as transcription factors.
p68 is a prototypic member of the DEAD box family of
proteins [9] and an established RNA helicase [10]. The
subsequent discovery of p72 [11] and the finding that p68
and p72 share remarkable homology (90% over the cen-
tral conserved core and 60% and 30% at the N- and C-ter-
minal extensions respectively) suggests that these proteins
may form a specific sub-group of DEAD box proteins and
may have similar, but perhaps subtly different, functions
in the cell, perhaps through interaction with different
RNA substrates or proteins. In vitro, both proteins exhibit
the RNA-dependent ATPase and RNA helicase activities
characteristic of members of the DEAD box family [10-14]
and have also been reported to catalyse rearrangement of
RNA structure via branch migration [13]. Moreover p68
and p72 can interact with each other, as well as self-asso-
ciate, and appear to preferentially form heterodimers in
cells [15]. This provides the potential for a wide range of
functions for p68 and p72 with the possibility of their co-
operation in some contexts.
More recently p68 and p72 have been shown to be
involved in a range of processes in the cell, including pre-
mRNA and pre-rRNA processing and alternative splicing
[16-18]. p68 and p72 have also been shown to be growth-
and developmentally-regulated [19-22] and, furthermore,
p68 appears to be over-expressed and poly-ubiquitylated
in colorectal tumours [23]. Interestingly p68 has been
shown to act as a transcriptional co-activator, specific for
the activation function 1 (AF-1) domain of estrogen
receptor alpha (ERα) [24]. This interaction was dependent
upon phosphorylation of AF-1 at serine118, a residue
phosphorylated by mitogen-activated protein kinase
(MAPK). Interestingly the RNA helicase function of p68
appeared to be dispensable for this activity as a mutant
p68 (Lys144 to Arg) in the ATP binding site (conserved
motif I) retained the ability to co-activate ERα, although
in a later study RNA binding appeared to be required [25].
p72 was subsequently shown to share this property and
both proteins were shown to interact with the activation
domain 2 (AD2) of p160 co-activators [25]. Furthermore
p68 was also found to interact with the CBP co-activator
and RNA polymerase II [26]. More recently p68 has been
shown to be recruited to the promoter of the ERα target
gene pS2 [27], suggesting a direct involvement in tran-
scriptional regulation.
In this report we explore further potential mechanisms
through which p68 and p72 may contribute to transcrip-
tional regulation. We find that, in some contexts, p68 and
p72 can also act as transcriptional repressors and that
these proteins exhibit clear promoter specificity in this
function. By directing GAL4-tagged p68/p72 (GAL4 DNA
binding domain aa1-147) to promoters containing GAL4
binding sites, we show that both p68 and p72 can repress
transcription from the herpes virus thymidine kinase (TK)
promoter but not the simian virus 40 promoter/enhancer.
Moreover, while p72 can repress transcription from the
Adenovirus major late promoter, p68 appears to have no
effect, suggesting that these proteins do not behave in an
identical way in all contexts. Furthermore we show, by co-
immunoprecipitation, that both p68 and p72 interact
with histone deacetylase 1 (HDAC1) and that HDAC1/
p68/p72 co-elute by gel filtration, indicating that they
exist in the same complex in the cell and suggesting a pos-
sible mechanism by which these proteins may exert their
repressive effect.
Results
p68 and p72 differentially repress constitutively active 
promoters/enhancers
In order to determine whether, in addition to their
reported role as co-activator proteins [25], p68 and p72Page 2 of 15
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11Effect of GAL4-tagged p68 and p72 on transcriptional activity as measured by CAT assays using the TK-CAT, MLP-CAT and SV40-CAT promoter-reporter lasmids, each harbouring 5 copies of a GAL4 binding ite f ed o the promoterFigure 1
Effect of GAL4-tagged p68 and p72 on transcriptional activity as measured by CAT assays using the TK-CAT, MLP-CAT and 
SV40-CAT promoter-reporter plasmids, each harbouring 5 copies of a GAL4 binding site fused to the promoter. The 
pcDNA3-GAL4 expression vector (pcG4) was used as a control. In each case U2OS cells were co-transfected with pcG4 or 
plasmids expressing GAL4-tagged p68/p72 (p68G4/p72G4) and the appropriate promoter-reporter construct. The amounts of 
DNA transfected were: pcG4-, p68G4-/p72G4- 1 µg; TK-CAT- 2.5 µg; MLP-CAT- 9 µg; SV40-CAT- 0.5 µg. The amount of 
DNA used had been previously titrated to achieve appropriate levels of baseline CAT activity. a) Transcriptional repression by 
p68 and p72 as measured by CAT activity, which is shown as % conversion of 14C-labelled chloramphenicol to acetylated 
forms. The data represent results from 5 independent assays, which were each performed in triplicate. b) Western blot, using 
a GAL4-specific antibody, showing expression levels of the pcG4, p68G4 and p72G4 plasmids.
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11Control CAT assays to examine repression of the TK-CAT promoter-reporter in U2OS cells by p68/p72Figu e 2
Control CAT assays to examine repression of the TK-CAT promoter-reporter in U2OS cells by p68/p72. The amounts of 
DNA transfected in each assay are indicated below and in all cases the % conversion of 14C-labelled chloramphenicol to 
acetylated forms is shown as an average of three independent experiments. a) Effect of untagged p68/p72 on TK-CAT tran-
scription. 7.5 µg of control pcDNA3 vector, pcDNA3-p68 (p68) or pcDNA3-p72 (p72) were co-transfected with 2.5 µg of TK-
CAT. b) Effect of GAL4-tagged p68 and p72 on transcriptional activity of a TK-CAT promoter-reporter which incorporated a 
1.6 kb DNA 'spacer' between the GAL4 binding sites and the promoter (TK-S-CAT). 1 µg of pcDNA3-GAL4 (pcG4) or GAL4-
tagged p68/p72 (p68G4/p72G4) were co-transfected with 5 µg of TK-S-CAT. The amount of TK-S-CAT had previously been 
titrated to achieve an appropriate baseline level of CAT activity. c) Titre of repression of TK-CAT activity by GAL4-tagged 
p68/p72. 2.5 µg of TK-CAT were co-transfected with different amounts of pcG4 vector, p68G4 and p72G4 as indicated. d) 
Effect of p300 and CBP on repression of TK-CAT transcription by GAL4-tagged p68/p72. 2.5 µg of TK-CAT were co-trans-
fected with 1 µg of pcG4 vector, p68G4 or p72G4 together with 6.5 µg of either bluescript (as control) or p300/CBP.
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11helicases have any intrinsic transcriptional activity we
generated plasmids to express p68-/p72-GAL4 DNA bind-
ing domain (aa1-147) fusion proteins (p68G4 and
p72G4). U2OS cells were then co-transfected with p68G4,
p72G4, or GAL4-tagged pcDNA3 (pcG4) plasmid as a
control, and a Herpes virus thymidine kinase promoter/
chloramphenicol acetyl transferase (CAT) reporter plas-
mid (TK-CAT) bearing 5 copies of the GAL4 binding site,
and CAT activity was measured in standard assays. The
amount of TK-CAT used had previously been titrated to
give a basal level of activity within the linear range of
measurement in the CAT assay system used (data not
shown). Interestingly, we observed a marked decrease in
CAT activity for both p68G4 and p72G4 (Figure 1a). This
was confirmed using other cell lines, including MCF-7
and 293 HEK (data not shown). As many transcription
factors have been shown to act differentially depending
upon promoter context [28], we also tested the transcrip-
tional activity of p68 and p72 with the Adenovirus major
late promoter (MLP-CAT), and the SV40 promoter/
enhancer (SV40-CAT). In each case we used the same
amount of p68G4/p72G4 DNA as previously and appro-
priate amounts of the reporter constructs that would give
similar basal levels of CAT activity using the GAL4 control
plasmid (Figure 1a). The amounts of reporter plasmid
DNA transfected had again been titrated previously to give
similar basal levels, which were within the linear range
(data not shown). We also confirmed that p68 and p72
were not limiting under these conditions (see Figure 2c
and data not shown). Surprisingly p68 and p72 acted dif-
ferentially with the MLP promoter, with p72 acting as a
repressor, while p68 had no significant effect on CAT
activity. Furthermore, neither p68 nor p72 repressed tran-
scription from the simian virus 40 promoter/enhancer
(SV40-CAT-Figure 1a). Western blotting, using an anti-
body against GAL4 confirmed that p68 and p72 were
expressed at similar levels in these cells (Figure 1b). Taken
together these results reveal not only that p68 and p72
appear to have a previously unknown transcriptional
repressive ability, but also that this activity is variable
depending on the promoter context.
The repression of transcription is an active process
To confirm that the repressive effect observed is not due to
an artefact of the assay conditions we initially repeated the
experiment with the TK-CAT reporter plasmid, using non-
tagged p68 or p72 or the pcDNA3 expression plasmid vec-
tor alone (Figure 2a). In this experiment neither p68 nor
p72 significantly reduce transcription of the TK-CAT
reporter, suggesting that the repression observed with the
GAL4-tagged p68/p72 plasmids (Figure 1) is not due to
competing out of an essential factor required for TK-CAT
transcription but, instead, implies an active mechanism of
repression in which the p68/p72 proteins are required to
be directed to the TK-CAT promoter via the GAL4 tag.
The possibility still remained that p68 and p72 were
repressing transcription by direct interference with the
transcriptional machinery of the TK-CAT promoter (e.g.
perhaps by physically blocking the promoter). To rule out
this possibility, we used a similar TK-CAT promoter con-
struct, which had, however, a 1.6 kb DNA 'spacer' between
the GAL4 binding sites and the promoter (the inserted
DNA is reported to have no effect on transcription [29]).
Both GAL4-p68 and -p72 retained the ability to repress
transcription, almost to the same degree as previously
(Figure 2b). Furthermore, a titration using the GAL4- p68/
p72 fusion proteins clearly shows a dose-dependent con-
centration curve (Figure 2c) as would be expected for
active repression. In addition, p68 and p72 have been
observed to interact with p300/CBP co-activators [24,26].
Therefore it remained possible that the observed tran-
scriptional repression was due to competition for, or
interference with, p300/CBP. If this were the case co-
expression of p300/CBP would be expected to relieve
repression by p68/p72. As shown in Figure 2d, no such
relief of expression was observed. Thus our findings that
transcriptional repression by p68/p72 was dose-depend-
ent and not due to steric blocking of the promoter or com-
petition/interference with p300/CBP, suggest that it is an
active process.
Deletion experiments do not identify a distinct repression 
domain for p68 or p72 but reveal an activation domain
To determine whether specific regions or domains of p68
and p72 act as transcriptional repressors, we performed
CAT assays, again using the TK-CAT reporter, but with a
range of deletion derivatives of p68/p72 covering the
entire coding region. Deletion derivatives encompassing
domains between amino acids 1–478 and 1–474 for p68
and p72 respectively repressed transcription in this assay
while the C-terminal region for both proteins (aa 477–
614 for p68 and 468–650 for p72) acted as a strong tran-
scriptional activator (Figure 3a,3b). Residues 1–478 of
p68 and 1–474 of p72 include all the conserved motifs
that characterise the DEAD box family of proteins (Figure
3c). Within this conserved core we have shown that there
are three domains, which can independently repress tran-
scription (Figure 3c), while the complete region (aa 1–
478/474) can repress as well as the full-length respective
proteins. Additionally, the finding that the C-terminal
regions of p68 and p72 activate transcription is consistent
with earlier reports of transcriptional activation by p68/
p72 [25,26]. Interestingly, ATPase inactive mutants of p68
and p72 (in which the DEAD motif had been mutated to
NEAD) as well as the more recently identified p82 (a
derivative of p72 which uses an alternative non-AUG
upstream translation initiation codon [30]) also repress
transcription (Figure 3b). Thus ATPase and helicase activ-
ity appear to be dispensable for transcriptional repression
suggesting that this function of p68/p72 may not specifi-Page 5 of 15
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11cally require RNA unwinding; again this is consistent with
reports that helicase activity is not required for co-activa-
tion of ERα transcriptional activity [24,25] although
another report suggested that p68 helicase activity is
required for synergism with the transcriptional co-activa-
tors CBP/p300 [26].
p72 immunoprecipitates a HDAC activity
Many studies have implicated histone deacetlyase
(HDAC) proteins in active repression of transcription,
and many transcriptional repressors have been shown to
associate with HDACs [31]. To test whether the observed
transcriptional repression by p68 and p72 was dependent
on HDAC activity, CAT activity assays were performed as
before, using the TK-CAT and MLP-CAT reporter
plasmids, in the presence and absence of the HDAC inhib-
itor trichostatin A (TSA). The relief of repression by TSA
was then determined for p68-/p72-GAL4 compared with
that observed for the GAL4 vector alone since TSA will
also increase basal levels of transcription. No effect was
observed with the TK-CAT promoter (data not shown).
For the MLP-CAT promoter repression was relieved two-
fold in the case of p72 while no effect was seen with p68
(Figure 4a). This is not surprising since p68 does not
repress transcription from this promoter (Figure 1). These
findings therefore suggest that HDAC activity appears to
be important for transcriptional repression of the MLP
promoter by p72 and imply that repression of the TK-CAT
may employ a different mechanism [32].
To examine further the involvement of HDACs in tran-
scriptional repression by p68/p72 we determined whether
p68 and/or p72 co-immunoprecipitate a HDAC activity in
cells. Plasmids expressing myc-tagged p68 and p72 were
expressed in 293 cells (with myc tag plasmid vector as a
negative control) and the tagged proteins were immuno-
precipitated from cell lysates using the myc epitope anti-
body, 9E10. Equal amounts of immunoprecipitated
protein bound to the antibody, as confirmed by western
blotting (Figure 4b), were then used in an HDAC activity
assay (Biomol) in the presence and absence of TSA. In this
assay (Figure 4c) p72 was found to co-immunoprecipitate
a HDAC activity, which is abolished by TSA, while p68 did
not. These findings are consistent with p72 interacting
with a HDAC and repressing transcription in a HDAC-
dependent manner.
p68 and p72 associate with HDAC1 in cells
Three classes of HDACs have been described. Class I
HDACs, which include HDAC1, 2 and 8, are expressed in
the nucleus and have been shown to bind several tran-
scription factors and to mediate transcriptional repression
[31]. Since HDAC1 is the prototypical member (in mam-
malian cells) and has been well studied we decided to
examine whether p68 and/or p72 associate with HDAC1
in cells. We had previously shown that a large proportion
of p68 and p72 co-elute by gel filtration [15]. Therefore
we examined fractions from a DNAse/RNAse-treated 293
cell lysate, which had been separated by gel filtration, by
western blotting using antibodies against p68, p72 and
HDAC1, and showed that a significant proportion of
HDAC1 co-elutes with the majority of p72 and a substan-
tial proportion of p68 in the cell in complexes that are of
a size consistent with p68/p72 interacting with HDAC1
(Figure 5). Since co-elution does not, in itself, indicate an
interaction, we went on to examine whether p68 and or
p72 co-immunoprecipitate with HDAC1 from cell lysates.
For p68, nuclear extracts were prepared from U2OS cells
and HDAC1 was immunoprecipitated with an HDAC1-
specific antibody. Immunopreciptiated proteins were
then separated by SDS-PAGE and the presence of p68 was
detected by western blotting with a p68-specific antibody
(Figure 6a). As currently available antibodies against p72
cross react with other nuclear proteins [15] 293 cells were
transfected with myc-tagged p72 and interactions between
the myc-tagged p72 and HDAC1 were examined. In this
case, therefore, nuclear extracts were prepared from trans-
fected cells, HDAC1 was immunoprecipitated as before
and associated myc-tagged p72 was detected by western
blotting using the myc epitope-specific antibody, 9E10
(Figure 6b). In each case, the presence of HDAC1 in the
immunoprecipitate was confirmed by western blotting
with the HDAC1-specific antibody (Figure 6a,6b). As an
additional control we carried out a reciprocal co-immuno-
precipitation experiment in which nuclear extracts from
293 cells transfected with myc-tagged p68/p72 were pre-
pared, the myc-tagged p68/p72 proteins were immuno-
precipitated using the myc epitope-specific antibody and
associated HDAC1 was detected by western blotting using
the HDAC1-specific antibody (Figure 7a). Cells that had
not been transfected were used as a control. Additionally,
since deletion derivatives encompassing residues 1–478
of p68 and 1–474 of p72 can repress transcription as well
as the respective full-length proteins, we examined
whether these deletions could co-immunoprecipitate
with HDAC1. We therefore transfected 293 cells with
GAL4-tagged proteins containing residues 1–478 of p68
and 1–474 of p72, prepared nuclear extracts, immunopre-
cipitated HDAC1 and western blotted for associated
GAL4-tagged p68/p72 with a GAL4-specific antibody. As
shown in Figure 7b, these deletion derivatives co-immu-
noprecipitate efficiently with HDAC1, suggesting that this
region of p68/72 interacts with HDAC1. These findings
thus indicate that p68 and p72 associate with HDAC1 in
cells and that the interaction appears to be mediated by
the regions which, in our system, are responsible for the
transcriptional repression activity of p68 and p72. Moreo-
ver, since the immunoprecipitations were performed with
extracts that had been treated with DNase/RNase (seePage 6 of 15
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11Deletion mapping of potential repression/activation domains in a) p68 and b) p72 as observed in CAT assays using the TK-CAT promoter-reporter plasmidFigure 3
Deletion mapping of potential repression/activation domains in a) p68 and b) p72 as observed in CAT assays using the TK-CAT 
promoter-reporter plasmid. The pcDNA3-GAL4 expression vector (pcG4) and full-length GAL4-tagged p68/p72 were used as 
controls. All p68/72 deletion derivatives were expressed as GAL4-tagged fusion proteins in pcG4 and included the amino acids 
indicated. Additional proteins tested in this assay included the ATPase/helicase GAL4-tagged inactive mutants of p68/p72 
(p68N/p72N) and the alternative upstream initiation product of the p72 gene (p82). The amounts of DNA used in the transfec-
tions were; TK-CAT- 2.5 µg; pcG4 and all p68/p72 constructs- 1 µg. The % conversion of 14C-labelled chloramphenicol to 
acetylated forms is shown as an average of five independent experiments. c) Diagram correlating the deletion end-points to the 
position of the motifs conserved in the DEAD box family of proteins.
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11The involvement of HDAC activity in transcriptional repression by p68/p72Figure 4
The involvement of HDAC activity in transcriptional repression by p68/p72. a) Relief of p68/p72 repression of MLP-CAT tran-
scription by TSA. 1 µg of pcDNA3-GAL4 (pcG4) or GAL4-tagged p68/p72 (p68G4/p72G4) were co-transfected with 9 µg of 
MLP-CAT and TSA was added 16 hr after transfection, at a final concentration of 300 nM. The values for p68G4 and p72G4 
are given relative to the baseline value for the pcG4 vector control, which was set at 1, and represent the average from three 
experiments. b) Immunoprecipitation/western blotting of myc-tagged p68 and p72 from 293 cells expressing these proteins. 
Myc-tagged proteins were immunoprecipitated with the anti-myc epitope antibody, 9E10, and western blotted with the same 
antibody to detect the presence of p68-myc and p72-myc fusion proteins. A myc-tagged pSG5 vector control is included. 
pSG5, p68 and p72 all refer to myc-tagged versions. H denotes cross reaction with the antibody heavy chain. Molecular weight 
markers (in kDa) are indicated. Equal amounts of these immunoprecipitated proteins were used in the HDAC activity assay 
shown in c. c) HDAC activity assay of immunoprecipitated p68 and p72 (see b). HDAC activity in the presence and absence of 
TSA is shown relative to that of the myc-tagged pSG5 vector control, which was set at 1, and represent the average from three 
experiments.
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HDAC1 are not mediated by nucleic acid.
Discussion
We have shown that the highly related DEAD box RNA
helicases p68 and p72 act as repressors of transcription in
a promoter-context manner. When targeted to the TK-CAT
promoter-reporter construct they both strongly repress
transcription (Figure 1). Furthermore, this transcriptional
repression does not appear to be due to either squelching
or physical blocking of the transcription apparatus (Figure
2), implying an active transcriptional mechanism. Moreo-
ver repression of TK-CAT was observed in several cell lines
(U2OS, 293, MCF-7) suggesting that it is not cell line
dependent. In order to determine whether this repression
activity exhibited any promoter specificity we also tested
the ability of p68 and p72 to repress transcription of other
constitutively active promoter-reporter constructs with
high basal levels of transcription, namely MLP-CAT and
SV40-CAT. Interestingly MLP-CAT revealed a difference in
the ability of p68 and p72 to repress transcription, with
p72 strongly repressing transcription of this promoter-
reporter and p68 having no effect (Figure 1). This obser-
vation suggests that, although highly homologous (70%
overall identity at the amino acid level [11]) p68 and p72
proteins may act differently in some contexts, perhaps
through the association with different protein partners.
Neither p68 nor p72 repressed transcription of SV40-CAT
(Figure 1) suggesting that the repression by p68 and p72
is promoter context-dependent, an observation that has
been reported for other transcription factors [33]. These
findings thus are consistent with the observed repression
activity of p68/p72 being an active process. Interestingly,
in this context, another DEAD box protein DP103
(Ddx20) has been found to act as a co-repressor of the Ets
repressor METS/PE1 [34].
Using a series of deletion derivatives of p68 and p72 we
identified three domains, within the core conserved
among the DEAD box family of proteins, which can
independently repress transcription (Figure 3c). Moreover
regions encompassing residues 1–478 of p68 and 1–474
of p72, which contain the complete conserved core (Fig-
ure 3c), can repress transcription as well as the respective
full-length proteins (Figure 3a,3b). In contrast, the C-ter-
minal extension of both proteins acts as a transcriptional
activator in this context (Figure 3a,5) consistent with
earlier reports of these proteins acting as transcriptional
co-activators [24,25]. Thus, using this system, we have
shown that there are separable transcriptional repression
and activation domains within p68 and p72.
Since HDAC proteins have been extensively implicated in
the repression of transcription, it was important to exam-
ine whether these proteins are likely to play a role in tran-
scriptional repression by p68 and/or p72. Firstly, the
ability of the HDAC inhibitor, TSA, to relieve repression
was examined. No effect was observed on repression of
TK-CAT (data not shown) implying the involvement of a
HDAC-independent mechanism in repression of the TK
promoter. In contrast, repression of MLP-CAT by p72 was
relieved two-fold compared with the vector control (Fig-
ure 4a) suggesting the involvement of HDACs in this proc-
ess. (Since p68 did not repress MLP-CAT transcription, the
lack of effect by TSA is not surprising.) Supporting these
data, p72 was found to co-immunoprecipitate a HDAC
activity which was abolished by the addition of TSA, while
p68 did not (Figure 4b). We chose to investigate whether
p68 and/or p72 associate with HDAC1, since it is a well-
studied example of Class I HDACs. Both p68 and p72 co-
immunoprecipitate with HDAC1 (Figures 6 and 7);
furthermore HDAC1, p68 and p72 co-elute in similar
sized complexes by gel-filtration, which are of an appro-
priate size (Figure 5) supporting the idea of interactions
between p68/p72 and HDAC1 in cells. Moreover, the
finding that these proteins co-immunoprecipitate and co-
elute from extracts which had been treated with DNase/
RNase suggest that these represent protein-protein inter-
actions rather than merely interactions via nucleic acid.
While an interaction between HDAC1 and p68 is not sup-
ported by the results of the HDAC assay, or the TSA exper-
iment, it is possible that, in some instances, p68 does
recruit HDAC1 and that this mechanism is not being trig-
gered in the MLP-CAT assay or HDAC assay. Alternatively,
it is possible that the observed co-immunoprecipitation of
p68 and HDAC1 is occurring through the interaction
between p68 and p72 [15] or that HDAC1 associated with
p68 may have other, possibly non-transcriptional, roles
[35,36]. However, the data are entirely consistent with
p72 recruiting HDAC1 to achieve active repression of
transcription. Future investigations should also reveal
whether the differential ability of p68 and p72 to recruit
active HDAC proteins is responsible for the difference
observed upon the MLP promoter.
Our attempts at correlating the different repressive func-
tions of p68 and p72 to specific domains of the respective
proteins, using deletion derivatives, were unsuccessful, as
the equivalent regions of both either caused transcrip-
tional repression or activation. While this might suggest
that both helicases repress transcription in the same man-
ner, it is more likely that the HDAC recruitment by p72
may be an additional mechanism of repression, used at
specific promoters. We also cannot rule out the
recruitment of other repression complexes at this stage.
Our findings that p68 and p72 differ in their ability to
repress the MLP promoter and to recruit HDAC activity
suggest that, at least in some contexts, p68 and p72 repress
transcription by different mechanisms.Page 9 of 15
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11Western blots showing gel filtration elution profiles of p68, p72 and HDAC1Figure 5
Western blots showing gel filtration elution profiles of p68, p72 and HDAC1. p68, p72 and HDAC1 in the fractions were 
detected by western blotting using appropriate antibodies. Note that the antibody raised against p72 also recognises p82 and 
cross-reacts with NFAR-2 [15]. All lysates had been treated with DNase and RNase prior to gel filtration. The void volume and 
elution position of the Pharmacia FPLC size markers are indicated, as are molecular weight markers (in kDa).
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11Co-immunoprecipitation of a) p68 and b) p72 with HDAC1Figure 6
Co-immunoprecipitation of a) p68 and b) p72 with HDAC1. a) HDAC1 was immunoprecipitated from U2OS nuclear extracts 
using an HDAC1-specific antibody. Immunoprecipitated proteins were separated by SDS-PAGE and the presence of HDAC1 
and associated p68 was detected by western blotting with p68- and HDAC1-specific antibodies. b) HDAC1 was immunopre-
cipitated from nuclear extracts of 293 cells expressing myc-tagged p72 using an HDAC1-specific antibody. Immunoprecipitated 
proteins were separated by SDS-PAGE and the presence of HDAC1 and associated myc-tagged p72 was detected by western 
blotting with HDAC1- and myc epitope- specific antibodies. In both experiments a control immunoprecipitation (IP) was per-
formed using an irrelevant rabbit IgG. An aliquot of nuclear extract (NE) was also included in the western blots (west.) as an 
additional control. H denotes cross reaction with the antibody heavy chain. Molecular weight markers (in kDa) are indicated.
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BMC Molecular Biology 2004, 5:11 http://www.biomedcentral.com/1471-2199/5/11a) Reciprocal co-immunoprecipitation of p68 and p72 with HDAC1Figure 7
a) Reciprocal co-immunoprecipitation of p68 and p72 with HDAC1. Myc-tagged p68 and p72 were immunoprecipitated from 
nuclear extracts of 293 cells expressing these proteins using a myc epitope-specific antibody and associated HDAC1 was 
detected by western blotting with an HDAC1-specific antibody. 293 cells, which had not been transfected, were used as con-
trol. b) Co-immunopreciptiation of p68/p72 deletion derivatives with HDAC1. HDAC1 was immunoprecipitated from nuclear 
extracts of 293 cells expressing GAL4-tagged p68 and p72 deletion derivatives, which encompass residues 1–478 and 1–474 of 
p68 and p72 respectively. Associated p68/p72 were detected by western blotting with a GAL4-specific antibody. 293 cells, 
which had not been transfected, were used as control. NE-nuclear extract, IP-immunopreciptiation. Molecular weight markers 
(in kDa) are indicated.
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transcription in a differential manner dependent upon
promoter context. It will be important to determine which
endogenous promoters are subject to repression by p68/
p72 in a physiological context. However, until the signal
transduction pathways, which target these proteins to the
appropriate promoters, are elucidated it will be necessary
to use a targeting system (such as GAL4) to undertake a
molecular analysis of transcriptional repression by p68
and p72. Since it is now clear that p68/p72 can act both to
activate and repress transcription future work will involve
dissection of the transcriptional activation/repression
complexes in which p68 and p72 are involved, as well as
characterisation of the molecular 'switch' which
determines whether these proteins will be part of tran-
scriptional activation or repression complexes.
Conclusions
We have shown that the highly related RNA helicases p68
and p72 can repress transcription in a promoter context-
dependent manner. Both proteins associate with HDAC1,
a well-established transcriptional repressor protein. Strik-
ingly, however, p68 and p72 behave differently in their
ability to repress transcription from different promoters
and in their ability to recruit HDAC activity suggesting
that they may, at least in some contexts, repress transcrip-
tion by different mechanisms.
Methods
Cell culture
U2OS human osteosarcoma cells and 293 human embryo
kidney cells were maintained at 5% CO2 at 37°C in
DMEM with 10% FBS, 2 mM L-glutamine, 100 units/ml
penicillin and 100 µg/ml streptomycin (all supplied by
Invitrogen).
Plasmids
A pcDNA3-GAL4 expression plasmid was used to express
full-length and deletion derivatives of p68/p72/p82
tagged at the N-terminus with the DNA binding domain
(amino acids 1–147) of GAL4 [37]. The majority of dele-
tion derivatives were created by PCR and inserted, as
BamHI/EcoRI fragments, in frame with the GAL4 tag. The
CAT reporter constructs have been described previously:
TK-CAT [38], TK-Spacer-CAT [29], MLP-CAT and SV40-
CAT [39]. The MLP-CAT and SV40-CAT plasmids were a
kind gift from Douglas Dean (Washington University, St
Louis, USA), and the TK-spacer-CAT plasmid was kindly
provided by Dr. Alain Nepveu (McGill University,
Canada). Untagged p300, CBP, p68, p72 were expressed
from pcDNA3. A myc-tagged derivative of pSG5 (Strata-
gene) [15] was used to express the myc-tagged p68/p72 or
the myc epitope alone as negative control.
Antibodies
p68: The antibodies used were the mouse monoclonal
antibody PAb 204 and the rabbit polyclonal antibody
2906, generated against the C-terminal 15 amino acids of
p68 [19]. PAb 204 was originally generated against the
SV40 large T antigen but it cross-reacts with p68 [9]. It is
specific for p68 in cells that are not infected or trans-
formed by SV40. p72: A rabbit anti-peptide polyclonal
antibody generated against amino acids 624 to 638 [15]
was used to detect p72/p82 in fractions from gel filtration.
Myc epitope: A mouse monoclonal antibody (9E10) was
used to detect proteins tagged with the myc epitope
(MRQKLISEEDL). HDAC1: A rabbit polyclonal antibody
(Oncogene Research Products) was used both for immu-
noprecipitation and western blotting. GAL4- a mouse
monoclonal antibody (Santa Cruz) was used to detect
GAL4-tagged proteins. A negative control rabbit IgG anti-
body for immunoprecipitation was obtained from R&D
systems and appropriate anti-mouse and anti-rabbit sec-
ondary antibodies were obtained from DAKO.
Transient transfections and chloramphenicol acetyl-
transferase (CAT) assays
3×105 U2OS cells were seeded for transfections, which
were performed as previously described [38]. Cells were
co-transfected with the appropriate CAT reporter con-
struct and GAL4-tagged p68/p72, and in each case the
DNA was made up to a total of 10 µg with Bluescript DNA
(Stratagene). CAT activity was determined 48 hr after
transfection using 100 µg of total protein from cleared
whole cell lysates. Typically each experiment was per-
formed in triplicate within each assay, and each assay was
repeated 3 to 5 times. Where applicable, the HDAC inhib-
itor Trichostatin A (TSA) (Upstate Biotechnology) was
added, at a final concentration of 300 nM, 16 hr post
transfection.
Nuclear extract preparation and co-immunoprecipitation
Nuclear extracts were prepared from U2OS and 293 cells
essentially as described in [40] except that the NaCl con-
centration was reduced to 330 mM NaCl, then diluted to
150 mM NaCl (after nuclear lysis) and treated with
RNAse/DNAse. The extract was pre-cleared in buffer D [20
mM Hepes (pH7.9), 150 mM NaCl, 0.5 mM DTT, 20% (v/
v) glycerol, 10 mM NaF and protease inhibitor cocktail
(Roche)] with protein G sepharose beads for 30 min. at
4°C. Immunoprecipitations were carried out in the pres-
ence of appropriate antibodies and protein G sepharose
beads for one hour at 4°C. After washing in buffer D plus
0.1% Igepal (Sigma), immunoprecipitated proteins were
separated by SDS-PAGE and western blotted using stand-
ard conditions and appropriate primary and secondary
antibodies. Immunoreactive proteins were detected using
the ECL method (Amersham).Page 13 of 15
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293 cell lysates were prepared in RIPA buffer [50 mM Tris-
HCl (pH8.0), 150 mM NaCl, 1% Igepal, 0.1% SDS, 1%
Na deoxycholate, 1 mM EDTA and protease inhibitor
cocktail (Roche)]. After treatment with RNase/DNase,
lysates were fractionated on a Pharmacia Superose 6 HR
column in 50 mM Tris-HCl (pH7.5), 150 mM NaCl, 10%
glycerol and 1 mM benzamidine, using a Pharmacia AKTA
FPLC system. 0.5 ml fractions were collected and alternate
fractions were analysed by western blotting. Molecular
weight standards from Pharmacia were used to calibrate
the column.
HDAC assay
293 cells were transfected with either pSG5-myc vector,
pSG5-p68-myc, or pSG5-p72-myc. Cells were lysed in
buffer B 48 hr after transfection. The lysate was then
diluted in buffer A and myc-tagged proteins
immunoprecipitated with 9E10 (myc epitope) antibody
as described above. The HDAC assay employs Fleur de lys
substrate, which contains an acetylated lysine side chain
(Biomol) and was performed according to manufacturers
instructions. Antibody-bound beads were washed in
HDAC assay buffer prior to being added to the 96-well
plate, to remove immunoprecipitation buffer. Reactions
were incubated for 30 min at 37°C with or without the
addition of 1 µM TSA. Samples were excited at 360 nm
and emitted at 460 nm and were read in a fluorometer.
Typically each assay was performed 3 times.
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